Global Leading Market Research Publisher QYResearch announces the release of its latest report “Animal Gavage Needle - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032”. Based on current situation and impact historical analysis (2021-2025) and forecast calculations (2026-2032), this report provides a comprehensive analysis of the global Animal Gavage Needle market, including market size, share, demand, industry development status, and forecasts for the next few years.

For preclinical researchers, toxicologists, and pharmacologists, accurate oral dosing of laboratory animals is essential for drug efficacy and safety studies. Animal gavage needle addresses this as a slender metal or plastic needle designed for oral administration to experimental animals (mice, rats, rabbits). Its smooth, blunt tip avoids esophageal damage, while its slender body adapts to varying animal sizes. Connected to a syringe and inserted through the mouth into the stomach, it delivers measured amounts of medication, nutrient solutions, or test substances. A commonly used drug delivery tool in pharmacology, toxicology, and biomedical research, the animal gavage needle is essential for consistent, reproducible oral dosing in preclinical studies.

【Get a free sample PDF of this report (Including Full TOC, List of Tables & Figures, Chart)】
https://www.qyresearch.com/reports/6098046/animal-gavage-needle

Market Size and Growth Fundamentals

The global animal gavage needle market was valued at US$ 25.23 million in 2025 and is projected to reach US$ 32.57 million by 2032, growing at a CAGR of 3.8% from 2026 to 2032. In 2024, global production reached 2.18 million units, with an average selling price of US$ 11.50 per unit. Growth is driven by expanding preclinical research activity, drug discovery pipelines, and toxicology studies requiring oral dosing in rodent models.

Product Overview and Design Features

Animal gavage needle is engineered for safe, effective oral dosing:

Material: Stainless steel (reusable) or medical-grade plastic (disposable)

Tip Design: Smooth, rounded, blunt tip to prevent esophageal puncture or laceration

Length: Species-specific sizing (mouse: 25–40mm, rat: 50–75mm, rabbit: 75–100mm)

Gauge: Fine diameter (16–20 gauge) for small animal esophagus

Connection: Standard Luer lock or slip tip for syringe attachment

Key design considerations:

Atraumatic Tip: Prevents injury during insertion

Flexible Material: Plastic disposables offer flexibility for curved path

Rigid Construction: Metal reusable needles for consistent positioning

Graduated Marks: Depth indicators for consistent insertion depth

Market Segmentation: Needle Types and Species

The animal gavage needle market is segmented by needle type into:

Disposable: Single-use plastic needles; eliminates cross-contamination risk; convenient for high-throughput studies. Fastest-growing segment for GLP and safety studies.

Reusable: Stainless steel needles; autoclavable for repeated use; cost-effective for low-volume research. Largest segment for academic and general research.

By species/application, the market spans Mouse, Rat, and Other (rabbits, guinea pigs, hamsters):

Mouse: Largest segment (approximately 55%), driven by the mouse as the most common preclinical model

Rat: Significant segment (approximately 30%) for toxicology and pharmacology studies

Other: Rabbit, guinea pig, hamster for specialized studies

Competitive Landscape: Key Players

The animal gavage needle market features laboratory equipment suppliers and specialty animal research product manufacturers:

Company Key Strengths
Avantor (VWR) Global laboratory supply; animal research products
PetSurgical Animal surgery and laboratory equipment
SAI Infusion Technologies Infusion and gavage products specialist
AgnTho's European animal research products
New England Small Tube Precision metal tubing; reusable needles
AMC Inc. Laboratory and medical products
Xuanzun Biotechnology, Shanghai Huake, Shanghai Yuyan, Biosharp Chinese laboratory equipment suppliers
Recent Developments (Last 6 Months)

Several developments have shaped the animal gavage needle market:

Preclinical Research Funding: December 2025–January 2026 saw continued government and pharmaceutical funding for preclinical research, supporting demand for gavage needles.

GLP Compliance: Good Laboratory Practice (GLP) requirements for oral dosing in safety studies increased demand for disposable needles to eliminate cross-contamination.

Animal Welfare: Focus on refinement (3Rs principles) led to improved gavage needle designs minimizing trauma and distress.

High-Throughput Screening: Increased volume of in vivo studies requiring consistent, reproducible oral dosing.

Exclusive Insight: Disposable vs. Reusable Gavage Needles—Cross-Contamination Prevention vs. Cost Efficiency

A critical market dynamic is the divergence between disposable and reusable gavage needles based on study requirements and laboratory practices.

Disposable Needles (fastest-growing) are characterized by:

Cross-Contamination Prevention: No risk of carryover between compounds

GLP Compliance: Preferred for regulatory safety studies

Convenience: No cleaning or autoclaving required

Higher Per-Use Cost: US$ 1–5 per needle

Applications: GLP toxicology, multi-compound screening, safety assessment

Reusable Needles (largest volume) are characterized by:

Cost-Effective: Lower per-use cost with repeated sterilization

Durability: Stainless steel withstands multiple uses

Consistency: Same needle geometry across uses

Cleaning Required: Autoclaving between uses; cross-contamination risk if not properly cleaned

Applications: Academic research, single-compound studies, low-volume testing

Mouse vs. Rat Needles (species-specific design) are characterized by:

Mouse Needles: Shorter (25–40mm), finer gauge (18–20), smaller curvature

Rat Needles: Longer (50–75mm), larger gauge (16–18), larger curvature

Specialty Needles: Flexible plastic for rat oral dosing; rigid metal for mouse

A 2026 industry analysis indicated that disposable needles are gaining share in CRO and pharmaceutical settings where GLP compliance and contamination prevention are critical. Reusable needles remain dominant in academic research where budget constraints prioritize per-unit cost.

Technical Challenges and Innovation Directions

Key technical considerations in animal gavage needle development include:

Atraumatic Tip Design: Minimizing esophageal trauma while maintaining strength

Flexible Materials: Plastic needles for curved oral passage

Depth Control: Graduations for consistent dosing depth

Sterilization Compatibility: Autoclavable materials for reusable needles

Innovation focuses on:

Flexible Plastic Designs: Improved flexibility for easier insertion

Pre-Curved Needles: Anatomically shaped for specific species

Disposable Sterile Packaging: Ready-to-use sterile needles

Color-Coding: Gauge and length identification for error prevention

Conclusion

The animal gavage needle market is positioned for steady growth through 2032, driven by preclinical research activity, drug discovery pipelines, and GLP compliance requirements. For manufacturers, success will depend on species-specific designs, material quality (atraumatic tip), and the ability to serve both disposable and reusable segments. As preclinical oral dosing remains essential for drug development, animal gavage needles will continue as fundamental tools for pharmacology, toxicology, and biomedical research.

Contact Us:
If you have any queries regarding this report or if you would like further information, please contact us:
QY Research Inc.
Add: 17890 Castleton Street Suite 369 City of Industry CA 91748 United States
EN: https://www.qyresearch.com
E-mail: global@qyresearch.com
Tel: 001-626-842-1666(US)
JP: https://www.qyresearch.co.jp